WallStreetZenWallStreetZen

NASDAQ: LUCD
Lucid Diagnostics Inc Stock Forecast, Predictions & Price Target

Analyst price target for LUCD

Based on 2 analysts offering 12 month price targets for Lucid Diagnostics Inc.
Min Forecast
$2.50+152.53%
Avg Forecast
$2.75+177.78%
Max Forecast
$3.00+203.03%

Should I buy or sell LUCD stock?

Based on 2 analysts offering ratings for Lucid Diagnostics Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their LUCD stock forecasts and price targets.

LUCD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-27
lockedlocked$00.00+00.00%2024-03-27

1 of 1

LUCD vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
LUCD$0.99$2.75+177.78%Strong Buy
PXDT$3.24N/AN/A
IRIX$2.95N/AN/A
APYX$1.41$5.00+254.61%Strong Buy
CTSO$0.93$1.00+7.53%Hold

Lucid Diagnostics Stock Forecast FAQ

Is Lucid Diagnostics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: LUCD) stock is to Strong Buy LUCD stock.

Out of 2 analysts, 1 (50%) are recommending LUCD as a Strong Buy, 1 (50%) are recommending LUCD as a Buy, 0 (0%) are recommending LUCD as a Hold, 0 (0%) are recommending LUCD as a Sell, and 0 (0%) are recommending LUCD as a Strong Sell.

If you're new to stock investing, here's how to buy Lucid Diagnostics stock.

What is LUCD's Price Target?

According to 2 Wall Street analysts that have issued a 1 year LUCD price target, the average LUCD price target is $2.75, with the highest LUCD stock price forecast at $3.00 and the lowest LUCD stock price forecast at $2.50.

On average, Wall Street analysts predict that Lucid Diagnostics's share price could reach $2.75 by Mar 27, 2025. The average Lucid Diagnostics stock price prediction forecasts a potential upside of 177.78% from the current LUCD share price of $0.99.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.